Onesource Specialty Pharma

Onesource Specialty Pharma Goodwill/Assets

The Goodwill to Total Assets Ratio of Onesource Specialty Pharma (ONESOURCE.NS) as of Oct 21, 2026 is 46.62 %. In the previous year, Goodwill to Total Assets Ratio was 0.59 % — a change of 7,766.48% (higher).

Goodwill/Assets

46.62 %

YoY

7,766.48%

Last updated:

Goodwill to Total Assets Ratio of Onesource Specialty Pharma is 2026 46.62 % . Goodwill to Total Assets Ratio of Onesource Specialty Pharma was 2025 0.59 % . It decreases by 7,766.48% higher compared to the previous year.

The Onesource Specialty Pharma Goodwill/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill/Assets
Date
Goodwill/Assets
Jan 1, 2024
0.00 INR
Jan 1, 2025
0.59 INR
Jan 1, 2026
46.62 INR
The Onesource Specialty Pharma Goodwill/Assets history
YEARGoodwill/AssetsYoY
46.62 %+7,766.48%
0.59 %—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Onesource Specialty Pharma Stock analysis

What does Onesource Specialty Pharma do? Onesource Specialty Pharma Ltd operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO) within the Life Sciences Tools & Services industry. Based in Bangalore, Karnataka, the India-based company provides vertically integrated biopharma services, focusing on the development and manufacture of complex biologics, biosimilars, and vaccines. Its core offerings include prefilled syringes with or without safety devices, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors. The firm supports the development of complex biologics such as microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and ribonucleic acid (RNA) products. The company generates revenue by catering to a variety of capsule shapes and sizes through its integrated services. These services encompass formulations ranging from traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and su. By providing comprehensive biologics solutions, the firm serves clients requiring advanced manufacturing capabilities for diverse pharmaceutical delivery systems and therapeutic modalities. Onesource Specialty Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Onesource Specialty Pharma stock

Goodwill to Total Assets Ratio of Onesource Specialty Pharma is 46.62 % in 2026.

Goodwill to Total Assets Ratio of Onesource Specialty Pharma changed from 0.59 % to 46.62 %, representing a 7,766.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Goodwill to Total Assets Ratio Onesource Specialty Pharma since 2006 – with annual values, charts, and detailed analysis.

The Goodwill/Assets ratio shows what percentage of total assets consists of acquisition goodwill. High ratios may indicate impairment risk.

Goodwill to Total Assets Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill to Total Assets Ratio's Onesource Specialty Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Onesource Specialty Pharma

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Onesource Specialty Pharma